[Clinical study on the antilipemic effect of tiadenol (Eulip)].
The hypolipaemising action of thiadenol (Eulip) was evaluated in a mixed groups of patients with various forms of hyperdyslipidaemia and cardiovascular complications. Mention is made of the administration modalities adopted. The results obtained shows that the drug is significant with regard to blood triglyceride levels in patients in groups IV and II B, and to a lesser, though by no meansnegligible, extent with regard to total cholesterol in II A and II B patients. No signs of intolerance or side-effects were noted, even when anticoagulants were also being administered.
D002986:Clinical Trials as Topic; D005233:Fatty Alcohols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000145:classification / Q000188:drug therapy*; D008297:Male; D014280:Triglycerides / Q000097:blood
D005233:Fatty Alcohols; D014280:Triglycerides; C004568:tiadenol
Indagine clinica sull'effetto ipolipemizzante del tiadenolo (Eulip).